Kevin McCulloch, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), bought 25,000 shares at $4.38 ($110K) on 2025-06-13, disclosed to the SEC on 2025-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| XERS | SELL | 2026-09-01 | $127K | — | Filing → |
| XERS | SELL | 2026-08-04 | $120K | — | Filing → |
| XERS | SELL | 2026-07-02 | $723K | — | Filing → |